We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBCPW
12551
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$7K ﹤0.01%
30,291
-100,000
-77% -$38.2K
JGGCR
12552
DELISTED
Jaguar Global Growth Corporation I Right
JGGCR
$7K ﹤0.01%
+43,408
New +$7.08K
ELYS
12553
CALL
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$7K ﹤0.01%
10,000
-2,800
-22% -$3.77K
LCI
12554
CALL
DELISTED
Lannett Company, Inc.
LCI
$7K ﹤0.01%
2,925
-725
-20% -$1.8K
HYRE
12555
PUT
DELISTED
HyreCar Inc. Common Stock
HYRE
$7K ﹤0.01%
+10,700
New +$13.7K
PHCF
12556
DELISTED
Puhui Wealth Investment Management Co., Ltd.
PHCF
$7K ﹤0.01%
1,823
-2,107
-54% -$8.68K
SWETW
12557
DELISTED
Athlon Acquisition Corp. Warrant
SWETW
$7K ﹤0.01%
56,515
+307
+0.5% +$50
PBLA
12558
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
0
VISL
12559
PUT
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$7K ﹤0.01%
550
-215
-28% -$3.24K
CNSP icon
12560
CNS Pharmaceuticals
CNSP
$8.07M
0
CBIO
12561
Crescent Biopharma
CBIO
$637M
$6K ﹤0.01%
108
-17
-14% -$1.26K
IBIO icon
12562
PUT
iBio
IBIO
$71M
$6K ﹤0.01%
48
-49
-51% -$7.37K
INM icon
12563
InMed Pharmaceuticals
INM
$7.85M
$6K ﹤0.01%
+26
New +$9.95K
LIQT icon
12564
CALL
LiqTech
LIQT
$18.5M
$6K ﹤0.01%
+1,613
New +$13.9K
MRKR icon
12565
CALL
Marker Therapeutics
MRKR
$19M
$6K ﹤0.01%
1,750
-380
-18% -$1.26K
TWAV
12566
TaoWeave Inc
TWAV
$4.92M
$6K ﹤0.01%
+29
New +$7.22K
VEON icon
12567
VEON
VEON
$3.93B
$6K ﹤0.01%
614
-6,984
-92% -$93.2K
YCBD icon
12568
cbdMD
YCBD
$5.2M
$6K ﹤0.01%
38
-58
-60% -$13.7K
MTVA
12569
CALL
MetaVia Inc
MTVA
$7.69M
$6K ﹤0.01%
5
-1
-17% -$1.58K
BLUA.WS
12570
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$6K ﹤0.01%
57,376
-268
-0.5% -$54
GMBL
12571
PUT
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
-1
Closed -$20.7K
DMK
12572
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$6K ﹤0.01%
160
+9
+6% +$281
ADEX.WS
12573
DELISTED
Adit EdTech Acquisition Corp Warrants
ADEX.WS
$6K ﹤0.01%
114,715
-352,677
-75% -$81.2K
AGILW
12574
DELISTED
AgileThought Inc Warrant
AGILW
$6K ﹤0.01%
12,597
ALLG.WS
12575
DELISTED
Allego N.V. Warrants
ALLG.WS
$6K ﹤0.01%
13,653
-1,407
-9% -$1.05K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.